Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Dr. Reddy's Laboratories on Jan. 9 recalled 1,051 vials of the cancer drug Docetaxel, according to the FDA's enforcement report for the week of Jan. 17.
Baxter on Jan. 16 expanded a voluntary recall of its drug Nexterone, which is used to treat heart arrhythmias.
The FDA expects the national saline bag shortage to improve in the coming weeks and months, but warns of a potential IV container shortage, according to Reuters.
Hospitals are strained for resources, space and staff members amid the 2017-18 flu season, highlighting the U.S. healthcare system's lack of preparedness for a mass pandemic or other medical emergencies, according to NBC News.
The FDA and Department of Defense's Office of Health Affairs on Tuesday unveiled a joint program to expedite the development and regulatory review of medical products for American military personnel.
GV, the venture capital arm of Google's parent Alphabet, is backing a U.K. company that is developing the world's first vaccine to combat all types of flu, reports Reuters.
After announcing plans to lay off 14,000 employees to shore up finances, Teva Pharmaceutical Industries is taking another step to bolster its financial profile. Its board of directors decided Wednesday to take a 50 percent pay cut until further notice,…
Here are the five latest drugs or medical devices approved by the FDA since Dec. 22.
The FDA on Friday expanded approval for AstraZeneca Pharmaceuticals' cancer drug, Lynparza, to treat certain forms of breast cancer.
President Donald Trump responded to North Korean leader Kim Jong Un's nuclear button comments on Twitter last week, causing a large spike in sales for an anti-radiation drug, reports Kaiser Health News.